Literature DB >> 21717156

Synergistic anti-inflammatory effect of Radix Platycodon in combination with herbs for cleaning-heat and detoxification and its mechanism.

Yu-Hang Li1, Feng-Jie Zheng, Ying Huang, Xiang-Gen Zhong, Ming-Zhang Guo.   

Abstract

OBJECTIVE: To investigate the synergistic anti-inflammatory effect of Radix Platycodon in combination with herbs for cleaning-heat and detoxification and its mechanism for Fel-targeting.
METHODS: Forty Wistar rats were randomly divided into five groups (8 per group): the sham-operated group, model group, Radix Platycodon group, Flos Lonicera and Fructus Forsythia (LF) group, and Radix Platycodon, Flos Lonicera and Fructus Forsythia combination (PLF) group, using a random number table. A rat chronic obstructive pulmonary disease (COPD) model was established by passive smoking and intratracheal instillation of lipopolysaccharide (LPS). The treatments started from the 15th day of passive smoking for a total duration of 14 days. At the end of the treatment, changes in the following measurements were determined: lung histopathology, inflammatory cytokines including tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β) and interleukin IL-1β (IL-1β) in bronchoalveolar lavage fluid (BALF), and mRNA expression of endogenous active substance intestinal trefoil factor 3 (TFF3) in the lung tissue.
RESULTS: Light microscopy showed that compared with the sham-operated group, rats in the COPD model group had disrupted alveolar structure, collapsed local alveoli, significantly widened or even fused alveolar septa, and massive infiltration of inflammatory cells in the alveolar wall and interstitium. In addition, significant bronchial epithelium hyperplasia, partially shed epithelia, and marked inflammatory cell infiltration in the bronchial wall and its surrounding tissues were noticed. Electron microscopy showed that rats in the model group had degeneration of alveolar type II epithelial cell; reduction, breakage or even loss of cell surface microvilli; swollen mitochondria with disappearing cristae and vacuole-like structure; and, increased secondary lysosomes in alveolar macrophages. The TNF-α, TGF-β and IL-1β levels and white blood cell (WBC) count in BALF were significantly increased (P < 0.01 or P < 0.05) and TFF3 mRNA expression in the lung tissue was significantly reduced (P < 0.01). After treatment, the pathological morphology of lung injury was less severe in all three treatment groups. In addition, TGF-β and IL-1β and WBC count in BALF were decreased (P < 0.01 or P < 0.05), and TFF3 mRNA expression in the lung tissue was significantly increased in the PLF group (P < 0.01). Compared with the LF group, the IL-1β in BALF was significantly decreased P < 0.05), and TFF3 mRNA expression was significantly increased (P < 0.05) in the PLF group.
CONCLUSIONS: Radix Platycodon synergizes with herbs for cleaning-heat and detoxification in reducing inflammatory injury in a rat model of COPD. The synergistic anti-inflammatory effect is reflected in the improvement in pathological changes and in the reduction of IL-1β levels in BALF. The mechanism of such synergistic action may be related to its effect on maintaining the TFF3 mRNA expression and Fel-targeting function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717156     DOI: 10.1007/s11655-011-0763-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  8 in total

Review 1.  Structure of mammalian trefoil factors and functional insights.

Authors:  L Thim; F E B May
Journal:  Cell Mol Life Sci       Date:  2005-12       Impact factor: 9.261

Review 2.  Therapeutic implications of the pathophysiology of COPD.

Authors:  P T Macklem
Journal:  Eur Respir J       Date:  2010-03       Impact factor: 16.671

3.  Localization of TFF3, a new mucus-associated peptide of the human respiratory tract.

Authors:  A Wiede; W Jagla; T Welte; T Köhnlein; H Busk; W Hoffmann
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

4.  Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.

Authors:  Robert Newton; Neil S Holden; Matthew C Catley; Wale Oyelusi; Richard Leigh; David Proud; Peter J Barnes
Journal:  J Pharmacol Exp Ther       Date:  2007-02-22       Impact factor: 4.030

5.  Trefoil factor family 3 peptide promotes human airway epithelial ciliated cell differentiation.

Authors:  Pierre LeSimple; Isabelle van Seuningen; Marie-Pierre Buisine; Marie-Christine Copin; Margitta Hinz; Werner Hoffmann; Rodolphe Hajj; Steven L Brody; Christelle Coraux; Edith Puchelle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-28       Impact factor: 6.914

Review 6.  Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease.

Authors:  William C Bailey; Donald P Tashkin
Journal:  Proc Am Thorac Soc       Date:  2007-10-01

7.  [Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial].

Authors:  Ning Chen; Hui Li; Li-Yun Zhao; Jian-Bo Liu; Qin Huang; Tong-Han Wang; Xiao-Mei Hao
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-02

Review 8.  Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments.

Authors:  Alexandra Hicks; Seth P Monkarsh; Ann F Hoffman; Robert Goodnow
Journal:  Expert Opin Investig Drugs       Date:  2007-12       Impact factor: 6.206

  8 in total
  8 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 2.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

3.  Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expression.

Authors:  Liping Yang; Xueyan Sun; Yongli Zhan; Huijie Liu; Yumin Wen; Huimin Mao; X I Dong; Ping Li
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

4.  Long-Term Consumption of Platycodi Radix Ameliorates Obesity and Insulin Resistance via the Activation of AMPK Pathways.

Authors:  Chae Eun Lee; Haeng Jeon Hur; Jin-Taek Hwang; Mi Jeong Sung; Hye Jeong Yang; Hyun-Jin Kim; Jae Ho Park; Dae Young Kwon; Myung-Sunny Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

5.  Chemistry and pharmacology of the herb pair Flos Lonicerae japonicae-Forsythiae fructus.

Authors:  Yi-Ping Guo; Li-Gen Lin; Yi-Tao Wang
Journal:  Chin Med       Date:  2015-07-02       Impact factor: 5.455

6.  Specific Link between Lung and Large Intestine: A New Perspective on Neuropeptide Secretion in Lung with Herbal Laxative Stimulation.

Authors:  Xiang-Gen Zhong; Feng-Jie Zheng; Yu-Hang Li; Hong Xu; Qian Wang; Yu-Chao Liu; Miao Liu; Ruo-Han Wu; Yu-Shan Gao; Shu-Jing Zhang; Jin-Chao Zhang; Tian-Yu Zhang; Si-Hua Gao
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

7.  Micro-PET Imaging Demonstrates 3-O-β-D-Glucopyranosyl Platycodigenin as an Effective Metabolite Affects Permeability of Cell Membrane and Improves Dosimetry of [18F]-Phillygenin in Lung Tissue.

Authors:  Fukui Shen; Wenbo Wu; Man Zhang; Xiaoyao Ma; Qingxin Cui; Zhongyao Tang; Hao Huang; Tiantian Tong; Leefong Yau; Zhihong Jiang; Yuanyuan Hou; Gang Bai
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

8.  The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis.

Authors:  Jing-Bei Zhang; Hong-Liu Jin; Xiao-Ying Feng; Sen-Ling Feng; Wen-Ting Zhu; Hong-Mei Nan; Zhong-Wen Yuan
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.